Mana Bio
Latest round
- Seed
Last raised
- Oct 2023
Total raised
- $25M
Investors
- 5
About Mana Bio
bio, provides Lipid Nanoparticle-based delivery systems for various therapies. The company offers an artificial intelligence-based platform that combines machine learning and nanotechnology for the development of drug delivery systems for various therapies like vaccines and gene therapy. It helps develop gene therapy, which includes DNA and RNA-based therapeutics. Additionally, the firm also develops vaccines.
Who invested in Mana Bio
5 investors across 2 rounds
See all investors in Mana Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mana Bio
Who invested in Mana Bio?
Mana Bio has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mana Bio raised?
Mana Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Mana Bio last raise money?
Mana Bio's most recent round on record is a Seed, in Oct 2023.
What does Mana Bio do?
bio, provides Lipid Nanoparticle-based delivery systems for various therapies.
Where is Mana Bio headquartered?
Mana Bio is headquartered in Tel Aviv, Israel.
Which VCs invest in companies like Mana Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Mana Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Mana Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.